About
Lifelet Medical develops a fully synthetic, polymer-based biomimetic leaflet material for heart valve replacements intended to replace animal-tissue pericardium. The technology is designed to increase valve durability, reduce manufacturing cost and eliminate reliance on animal tissue for implantable heart valves.
Explore Lifelet Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.